Branded vial and pen-kit presentation. Confirm the available format, contents and packaging for this product.
GHK-Cu
A copper-binding tripeptide investigated in extracellular matrix and skin biology.
Listed content per unit- Presentation
- Vial presentation
- Local dispatch markets
- Australia · Canada · USA
- Availability
- Confirm by strength & location
- Documentation
- Request product & batch records
For qualified research enquiries. Listed content is not a dose or administration instruction.
The research context
GHK-Cu is a copper-binding tripeptide complex investigated in extracellular-matrix biology. Primary research includes fibroblast activity and collagen-related processes in cell culture.
The research description is about the molecule and laboratory evidence. It is not a claim that the listed vial is an approved injectable skin-rejuvenation product.
GHK-Cu: copper binding and matrix research
GHK is the tripeptide glycyl-L-histidyl-L-lysine. GHK-Cu describes its copper complex. A foundational fibroblast-culture study examined collagen synthesis after exposure to GHK-Cu, making extracellular-matrix biology a central part of its research context. Read the fibroblast study.
A separate experiment investigated connective-tissue accumulation in a rat wound-chamber model. These studies examine defined experimental materials and endpoints; they do not measure the performance of an Aurelis vial. Read the animal-model study.
What do the 50 mg and 100 mg listings mean?
They describe listed content per vial, rather than a concentration, recommended dose or amount per application. Compare the agreed material specification and the batch record when selecting a strength.
GHK-Cu as a single compound or a blend enquiry
The standalone entry is listed as GHK-Cu. The GLOW and KLOW source formulations abbreviate their component as GHK, so its full identity needs confirmation. Review the peptide blend comparison before treating a blend abbreviation as the same specification.
Useful details for a GHK-Cu document request
- The named material and copper-complex specification.
- The lot identifier, analytical identity evidence and reported test method.
- Measured content and the basis of any chromatographic purity result.
- Storage and stability information for the actual presentation.
Use the quality-documentation guide to distinguish molecular identity, analytical purity and measured content. These are separate questions.
Research context reviewed 30 September 2026.
What does GHK-Cu do?
Read our GHK-Cu guide for a simple explanation of skin and collagen research and what studies found.
Compare the listed amounts and requested unit counts in our GHK-Cu 50 mg vs 100 mg guide, then choose a vial or kit presentation for your enquiry.
What to include in your enquiry
Tell us your required compound, strength, presentation and destination country. If you have a particular analytical requirement, include the method or document you need so the team can match your request to the relevant specification.
Selected scientific references
These sources describe published research or a specific regulated medicine. They are not certificates for an Aurelis batch.
Explore related entries.
All compoundsBPC-157
A synthetic peptide studied in preclinical models of tissue response and repair.
TB-500
A thymosin beta-4-related research material; sequence and identity are batch-specific.
Connect with Aurelis
Your next enquiry
starts with the details.
Tell us the compound, listed content, preferred presentation and destination. Our team can discuss local availability and the documentation for your selected material.